PRLR and neoplasm: In postmenopausal women, plasma prolactin levels > 11 vs. ≤ 11 ng/mL were significantly associated with a higher risk of breast cancer overall, with no significant differences by PRLR or pSTAT5 tumor expression status (Table 3; Additional file 1: Figure S1A–1C).